Abstract
Treatment of prurigo nodularis is a challenge. No specific therapies are approved and data from clinical trials are rare. Based on our experience, case series, randomized controlled trials as well as the S2k guideline on chronic pruritus, we provide general principles and specific recommendations in this review.
MeSH terms
-
Anticonvulsants / therapeutic use*
-
Antidepressive Agents / therapeutic use*
-
Dermatologic Agents / therapeutic use*
-
Dermatology / standards*
-
Evidence-Based Medicine
-
Germany
-
Humans
-
Naltrexone / therapeutic use*
-
Practice Guidelines as Topic
-
Prurigo / complications
-
Prurigo / drug therapy*
-
Pruritus / etiology
-
Pruritus / prevention & control*
Substances
-
Anticonvulsants
-
Antidepressive Agents
-
Dermatologic Agents
-
Naltrexone